https://www.medrxiv.org/content/10.1101/2025.01.30.25321421v3

Effectiveness of the Influenza Vaccine During the 2024-2025 Respiratory Viral Season

Nabin K. ShresthaPatrick C. BurkeAmy S. NowackiSteven M. Gordon

ABSTRACT

Background The purpose of this study was to evaluate the effectiveness of the influenza vaccine during the 2024-2025 respiratory viral season.

Methods Employees of Cleveland Clinic in employment in Ohio on October 1, 2024, were included. The cumulative incidence of influenza among those in the vaccinated and unvaccinated states was compared over the following 25 weeks. Protection provided by vaccination (analyzed as a time-dependent covariate) was evaluated using Cox proportional hazards regression.

Results Among 53402 employees, 43857 (82.1%) had received the influenza vaccine by the end of the study. Influenza occurred in 1079 (2.02%) during the study. The cumulative incidence of influenza was similar for the vaccinated and unvaccinated states early, but over the course of the study the cumulative incidence of influenza increased more rapidly among the vaccinated than the unvaccinated. In an analysis adjusted for age, sex, clinical nursing job, and employment location, the risk of influenza was significantly higher for the vaccinated compared to the unvaccinated state (HR, 1.27; 95% C.I., 1.07 – 1.51; P = 0.007), yielding a calculated vaccine effectiveness of −26.9% (95% C.I., −55.0 to −6.6%).

Conclusions This study found that influenza vaccination of working-aged adults was associated with a higher risk of influenza during the 2024-2025 respiratory viral season, suggesting that the vaccine has not been effective in preventing influenza this season.

Summary Among 53402 working-aged Cleveland Clinic employees, we were unable to find that the influenza vaccine has been effective in preventing infection during the 2024-2025 respiratory viral season.

_______________

For more:

SUMMARY:

    1. THE FLU VACCINE INCREASES THE RISK OF CONTRACTING A NON-FLU RESPIRATORY ILLNESS BY 65%.
    2. THE FLU VACCINE DOESN’T REDUCE DEMAND ON HOSPITALS.
    3. THE FLU VACCINE DOESN’T PREVENT THE SPREAD OF THE FLU.
    4. THE FLU VACCINE FAILS TO PREVENT THE FLU ABOUT 65% OF THE TIME.
    5. REPEAT DOSES OF THE FLU VACCINE MAY INCREASE THE RISK OF FLU VACCINE FAILURE.
    6. DEATH FROM INFLUENZA IS RARE IN CHILDREN.
    7. THE FLU VACCINE DOESN’T REDUCE DEATHS FROM PNEUMONIA AND FLU.
    8. PATIENTS DON’T BENEFIT FROM THE VACCINATION OF HEALTHCARE WORKERS.
    9. FLU VACCINE MANDATES ARE NOT SCIENCE-BASED.

Excerpts:

Originally, the flu vaccine was a measure to protect the elderly, but go here for a blast from the past when four scientists researching the Flu vaccine during the 1960s found it to be ineffective and refused to give it to their own families.  The scientists state they were prevented from publishing their negative findings.

Despite this, the ineffective and dangerous vaccine has increasingly been pushed on everyone 6 months old and up, including pregnant women despite the fact the flu vaccine is linked to increased risk of miscarriage.

Now a recent Japanese study shows NO BENEFIT on hard outcomes: hospitalization and death. Another perfect example of how the massive push to vaccinate people for the flu has been a waste of time and effort.  Do not expect to read about this in the news.

Further demonstrating the diabolical history behind vaccines, the military mandated the Adenovirus vaccine for ‘cold-like symptoms’:

”…when it was shown that the vaccine contained a contaminant which caused cancer in laboratory animals, it was taken off the market, but that was 3 years after the division’s scientists have pointed out the danger…”

The Adenovirus vaccine (which contains live adenovirus Type 4 and type 7 can be shed in stool and and breast milk and infect contacts – particularly children, pregnant women, and those with immune system problems, as well as harming the unborn) is still available for United States military personnel.  It is not available to the general public.